Prostate cancer drugs that halve risk of dying: New hope for patients thanks to new treatment - Daily Mail
Sep 19, 2021 1 min, 23 secs

Thousands of men could live longer with prostate cancer after taking a new drug combination.

Around 10,000 men a year in the UK are estimated to have an aggressive form of prostate cancer, which is normally treated with hormone therapy and radiotherapy.

However the new British-led trial in a different group of men, whose prostate cancer had not spread, found abiraterone, taken for just two years, greatly improved their chances of survival.

Over six years, men given the combination of drugs including abiraterone were 51 per cent less likely to die than those on the normal treatment.

Only 18 per cent of them had seen the cancer spread through their body, compared with 31 per cent of those not given the combination. .

Another author, Nick James, professor of prostate and bladder cancer research at the Institute of Cancer Research and a consultant clinical oncologist at The Royal Marsden NHS Foundation Trust, said: ‘The results were spectacular – that is really the only word for it.

The new trial results, funded by Cancer Research UK and presented at the European Society for Medical Oncology Congress, show 15 per cent of men given the usual treatment died within six years. .

The women in the study, led by the MD Anderson Cancer Centre at the University of Texas, were given the drugs as the first treatment after their cancer had spread or come back

Dr Kotryna Temcinaite, from charity Breast Cancer Now, said: ‘This research brings women with secondary breast cancer new hope of precious extra time with loved ones.’

n A combination of two inhibitor drugs can stop some ovarian cancer tumours from growing for an average of 23 months, researchers at the Institute of Cancer Research found

1. China seeks to lift homework pressures on schoolchildren - BBC News
Oct 23, 2021 # politics 48 secs
2. Chicago Bulls player DeMar DeRozan buys $4.5M Chicago mansion from Michael Jordan's ex-wife - Chicago Tribune
Oct 20, 2021 # politics 19 secs
3. Miami private school makes bogus claims about vaccines while ordering pupils who get a shot to stay home for 30 days - CNN
Oct 19, 2021 # health 1 min, 20 secs
4. Here's where Americans are quitting their jobs the most
Oct 22, 2021 # breaking 2 secs
5. Exclusive: Here's how you'll know which games will run on Valve's Steam Deck - Rock Paper Shotgun
Oct 18, 2021 # technology 3 mins, 7 secs
6. MacBook Air Coming in 2022 Also Rumored to Feature Notch Design - MacRumors
Oct 17, 2021 # politics 33 secs
7. What Is Candidiasis of the Mouth - What to Know About Oral Thrush - Prevention.com
Oct 20, 2021 # health 1 min, 29 secs
8. Sony Now Allows Players To Buy Games They Redeemed Through PlayStation Plus - PlayStation Universe
Oct 20, 2021 # technology 30 secs
9. Stock Market and Bitcoin Flirt With Records: Live Business News - The New York Times
Oct 20, 2021 # politics 8 mins, 2 secs
10. Klein Investigations and Consulting present what they have on the Thomas Brown case to the community - KAMR - MyHighPlains.com
Oct 21, 2021 # health 8 secs
11. Meryl Streep, Sienna Miller & Kit Harington Among Stars Set For Scott Z. Burns’ Climate Change Anthology Series ‘Extrapolations’ For Apple - Deadline
Oct 19, 2021 # entertainment 57 secs
12. ACLU sues Oklahoma over law prohibiting critical race theory topics from being taught in schools - CNN
Oct 20, 2021 # politics 43 secs
13. Britney Spears says it's 'bittersweet' seeing sons Sean, 16, and Jayden, 15, grow up - Daily Mail
Oct 23, 2021 # entertainment 1 min, 9 secs
14. Weird radio waves from the heart of the Milky Way - EarthSky
Oct 17, 2021 # science 1 min, 7 secs
15. Forget the free Pixel Buds you get with your Pixel 6 pre-order? No worries, Google's got your back - PhoneArena
Oct 23, 2021 # technology 15 secs
16. In tree rings and radioactive carbon, signs of the Vikings in North America
Oct 20, 2021 # breaking 1 min, 7 secs

SUBSCRIBE

Get monthly updates and free resources.

CONNECT WITH US

© Copyright 2021 365NEWSX - All RIGHTS RESERVED